There are several investigators that have examined α-synuclein levels in the brain and CSF of patients with Alzheimer’s disease and primary α-synucleinopathies such as Parkinson’s disease and dementia with Lewy bodies [374,375,376]. Here, SNCA is linked to synucleinopathy.